Flux AI: DTBTE molecule

DTBTE molecule Flux Artworks

Illustration of organic molecule DTBTE in two states. One side is disordered and yellow, the other side shows crystalline green. Thermometer indicates 80 °C for conversion. Fluorescent effects show yellow in amorphous state and green in crystalline. Overlay features thiophene groups for isomerization. Subtle hydrogen bonds in crystalline. Background has soft texture for amorphous and sharp for crystalline. Layout is scientific and vibrant, suitable for chemistry journal.
4 images

Vibrant Scientific Illustration of DTBTE: Amorphous and Crystalline States with Fluorescent Emission and Thermal Conversion

DTBTE molecule
fluorescent emission
temperature scale
A scientific illustration depicts a DTBTE molecule in two states. One state is disordered and yellow, the other is ordered and green. A temperature scale shows cold crystallization at 80 °C. Arrows labeled thermal activation, solvent fuming, and mechanical shearing indicate transitions. The background is divided with soft clouds for amorphous and geometric shapes for crystalline.
2 images

DTBTE Molecular Phase Transition Illustration for Scientific Journals

reversible phase transition
DTBTE molecule
fluorescent emission
Scientific illustration showing a molecule of dimethyl-4,7-di(2-thienyl)-2,1,3-benzothiadiazole-5,6-dicarboxylate in two states. One disordered with a blue glow. The other ordered with a red-orange glow. Display thermometer indicating cold crystallization at 80 °C. Include labels for thermal activation, solvent fuming, mechanical shearing. Show switchable emission colors blue-green in amorphous and red-orange in crystalline. Overlay rotating thiophene groups and hydrogen bond networks in crystalline phase. Background split with soft cloudy texture and sharp geometric shapes. Faint representations of X-ray crystal structures and molecular orbitals.
4 images

Vibrant Scientific Illustration of Dimethyl-4,7-di(2-thienyl)-2,1,3-benzothiadiazole in Amorphous and Crystalline States

molecule
dimethyl-4,7-di(2-thienyl)-2,1,3-benzothiadiazole
phase transition